---
title: 'From Cell-Lines to cancer patients: Personalized drug synergy prediction'
date: '2024-05-08'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38718189/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1byXLWG-5Hn0_qdLgZYpDfLA2UWGhGNgZGereuo1rJN2aoAQXP&fc=20220814223158&ff=20240509180906&v=2.18.0.post9+e462414
source: (deep learning) AND ((leukemia) OR (lymphoma))
description: 'MOTIVATION: Combination drug therapies are effective treatments for
  cancer. However, the genetic heterogeneity of the patients and exponentially large
  space of drug pairings pose significant challenges for finding the right combination
  for a specific patient. Current in silico prediction methods can be instrumental
  in reducing the vast number of candidate drug combinations. However, existing powerful
  methods are trained with cancer cell line gene expression data, which limits their
  ...'
disable_comments: true
---
MOTIVATION: Combination drug therapies are effective treatments for cancer. However, the genetic heterogeneity of the patients and exponentially large space of drug pairings pose significant challenges for finding the right combination for a specific patient. Current in silico prediction methods can be instrumental in reducing the vast number of candidate drug combinations. However, existing powerful methods are trained with cancer cell line gene expression data, which limits their ...